Therefore, inflammatory cytokines, such as interleukin-6, and tumor necrosis factor-α, along with other novel sepsis biomarkers, such as presepsis, CD64, and soluble triggering receptor expressed on myeloid cells-1 (sTREM-1), can be collected continuously as new clinical variables in order to advance the prediction model. This evidence concerns the gene TNF and Sepsis.